• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

22.35 USD 0.36 1.64%

As of 09:29:30 ET on 12/17/2014.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +23.00% 3-Month: +2.90% 3-Year: +26.85% 52-Week Range: 17.93 - 23.05
1-Month: +0.99% 1-Year: +27.85% 5-Year: +21.56% Beta vs MXWO: 0.94

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 22.35
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2014-12-17) 22.35
Assets (M) (on 2014-11-28) 1,765.27
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-04-11) 0.35
Dividend Yield (ttm) 12.25

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.81

Top Fund Holdings for FPHAX

Filing Date: 10/31/2014
Name Position Value % of Total
Actavis plc 556,307 135,037,961 8.070%
Bristol-Myers Squibb Co 1,652,810 96,177,014 5.747%
Johnson & Johnson 876,200 94,436,836 5.643%
Novartis AG 910,498 84,394,060 5.043%
AstraZeneca PLC 1,041,800 75,988,892 4.541%
Teva Pharmaceutical Industries 1,189,389 67,164,797 4.014%
Valeant Pharmaceuticals Intern 498,627 66,274,189 3.960%
Perrigo Co PLC 390,552 63,054,620 3.768%
Merck & Co Inc 946,236 54,824,914 3.276%
Novo Nordisk A/S 1,206,200 54,496,116 3.257%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil